Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/31516
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2018-07-02T10:51:49Z-
dc.date.available2018-07-02T10:51:49Z-
dc.date.issued2017-
dc.identifier.urihttps://www.um.edu.mt/library/oar//handle/123456789/31516-
dc.descriptionB.SC.(HONS)NURSINGen_GB
dc.description.abstractOverview: Since 2013 there has been an interest in the use of nebulised hypertonic saline in infantile bronchiolitis. Later conflicting evidence has diminished earlier claims that it significantly reduced length of hospital stay. Research question: "Does the use of nebulised hypertonic saline solution reduce the duration of hospitalisation in infants admitted with bronchiolitis?" PICO elements: Population: Infants who are hospitalised for bronchiolitis; Intervention: Nebulised hypertonic saline with standard care; Comparator: Standard care alone; Outcome: Reduction in duration of hospitalisation; Studies: RCTs, Metaanalyses, Systematic Reviews Inclusion and exclusion criteria: Based on PICO elements, restricting to 'infants 0-24 months of age' and studies published in English, through 1996-2016. Literature search outcome: A finalised list of seven systematic reviews and metaanalyses of RCTs, and five select RCTs out of a series of twenty-four. Appraisal: The CASP tool and the Cochrane Collaboration 'risk of bias' tool indicated valid reviews, and later RCTs with greater bias, though the largest RCT was robust and locally applicable. Results: An updated meta-analysis of 20 RCTs involving 2169 participants was homogenously defined after exclusion of 4 outlier RCTs. It showed that hypertonic saline reduced length of hospital stay by 7 hours. Standard subgroup analysis in published reviews showed a greater effect in those hospitalised beyond 3 days, and when hypertonic saline was combined with nebulised adrenaline. The most locally applicable and largest RCT did not show that hypertonic saline reduced length of hospitalisation. All studies showed that hypertonic saline was safe. Conclusion: Hypertonic saline should be used only in those infants admitted with bronchiolitis not showing satisfactory improvement on standard care alone. Recommendations: The implementation of a pragmatic local protocol together with further specific RCTs, and literature searches not restricted to the English language.en_GB
dc.language.isoenen_GB
dc.rightsinfo:eu-repo/semantics/restrictedAccessen_GB
dc.subjectHospital utilisation -- Length of stayen_GB
dc.subjectBronchioles -- Diseasesen_GB
dc.subjectPediatric respiratory diseasesen_GB
dc.subjectHypertonic solutionsen_GB
dc.subjectAtomizersen_GB
dc.titleThe effect of nebulised hypertonic saline on the length of hospitalisation in infantile bronchiolitisen_GB
dc.typebachelorThesisen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.publisher.institutionUniversity of Maltaen_GB
dc.publisher.departmentFaculty of Health Sciences. Department of Nursingen_GB
dc.description.reviewedN/Aen_GB
dc.contributor.creatorFarrugia, Joanna-Frederica-
Appears in Collections:Dissertations - FacHSc - 2017
Dissertations - FacHScNur - 2017

Files in This Item:
File Description SizeFormat 
17BSNR27.pdf
  Restricted Access
5.84 MBAdobe PDFView/Open Request a copy


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.